Shenzhen New Industries Biomedical Engineering Co., Ltd. Operating Cash Flow for the year ending December 31, 2024: USD 185.78 M

Shenzhen New Industries Biomedical Engineering Co., Ltd. Operating Cash Flow is USD 185.78 M for the year ending December 31, 2024, a -7.00% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Shenzhen New Industries Biomedical Engineering Co., Ltd. Operating Cash Flow for the year ending December 31, 2023 was USD 199.77 M, a 43.24% change year over year.
  • Shenzhen New Industries Biomedical Engineering Co., Ltd. Operating Cash Flow for the year ending December 31, 2022 was USD 139.46 M, a 14.60% change year over year.
  • Shenzhen New Industries Biomedical Engineering Co., Ltd. Operating Cash Flow for the year ending December 31, 2021 was USD 121.69 M, a -18.67% change year over year.
  • Shenzhen New Industries Biomedical Engineering Co., Ltd. Operating Cash Flow for the year ending December 31, 2020 was USD 149.62 M, a 25.28% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities